Original Article
Modern Pathology (2008) 21, 491–497; doi:10.1038/modpathol.2008.8; published online 1 February 2008
Malignant transformation of hepatic adenomas
Shien T L Micchelli1, Perumal Vivekanandan1, John K Boitnott1, Timothy M Pawlik2, Michael A Choti2 and Michael Torbenson1
- 1Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 2Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Correspondence: Dr M Torbenson, MD, Department of Pathology, The Johns Hopkins University School of Medicine, 1503 East Jefferson, Room B314, Baltimore, MD 21231, USA. E-mail: mtorben@jhmi.edu
Received 12 March 2007; Revised 16 June 2007; Accepted 18 June 2007; Published online 1 February 2008.
Abstract
Hepatic adenomas are benign neoplasms of the liver that occur in several well-defined clinical settings, but principally that of excess hormone exposure. They have a small but poorly characterized risk of malignant degeneration. The clinical presentation and pathological findings were reviewed for all hepatic adenomas resected between January 1, 2003 and July 1, 2006. Immunohistochemistry for p53,
-catenin and
-fetoprotein (AFP) were performed on those cases with malignant transformation and exon 3 of
-catenin was amplified and sequenced. A total of 17 hepatic adenomas were resected and 3 showed malignant transformation. All three cases were in women with an age range of 23–33 years. The clinical presentations were vague abdominal pain. Histologically, the malignant transformation occurred within otherwise typical hepatic adenomas. Two of three cases showed patchy atypia throughout the hepatic adenoma. The hepatocellular carcinoma arose as distinct nodules directly within the adenomas, effectively ruling out synchronous lesions. The hepatocellular carcinomas were unifocal in two cases and multifocal in one case with the greatest dimensions of the hepatocellular carcinoma being 2.5, 2.2, and 1 cm. Immunostains for AFP and
-catenin were negative in both the hepatic adenomas and areas of hepatocellular carcinoma. p53 immunostaining was positive within the areas of malignant transformation in one case. No mutations or deletions were seen in exon 3 of the
-catenin gene for either the adenomas or the carcinoma. In conclusion, two of the cases that developed hepatocellular carcinomas showed cytological atypia in the background adenoma. The hepatocellular carcinomas arose as distinct nodules within the adenomas. No common molecular pathway of hepatocellular carcinogenesis was observed by examining AFP,
-catenin, and p53 immunostains and no
-catenin mutations or deletions were found.
Keywords:
hepatic adenoma, hepatocellular carcinoma,
-catenin
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Strategies for the management of hepatocellular carcinoma
Nature Clinical Practice Oncology Review (01 Jul 2007)
Strategies for the management of hepatocellular carcinoma
Nature Clinical Practice Oncology Review (01 Jul 2007)
RESEARCH
Hepatic Adenomas: Analysis of Sex Steroid Receptor Status and the Wnt Signaling Pathway
Modern Pathology Original Article
Nature Biotechnology Research (01 Mar 2009)
Modern Pathology Original Article

